Rafferty Asset Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-929
| Closed | -$31.5K | – | 1159 |
|
|
2022
Q4 | $31.5K | Sell |
929
-1,312
| -59% | -$44.5K | ﹤0.01% | 1117 |
|
|
2022
Q3 | $108K | Sell |
2,241
-2,519
| -53% | -$121K | ﹤0.01% | 1121 |
|
|
2022
Q2 | $271K | Buy |
4,760
+3,202
| +206% | +$182K | ﹤0.01% | 944 |
|
|
2022
Q1 | $126K | Sell |
1,558
-58
| -4% | -$4.69K | ﹤0.01% | 1161 |
|
|
2021
Q4 | $327K | Buy |
1,616
+512
| +46% | +$104K | ﹤0.01% | 1136 |
|
|
2021
Q3 | $298K | Buy |
1,104
+371
| +51% | +$100K | ﹤0.01% | 1129 |
|
|
2021
Q2 | $189K | Buy |
+733
| New | +$189K | ﹤0.01% | 1233 |
|
|
2021
Q1 | – | Sell |
-1,113
| Closed | -$284K | – | 1168 |
|
|
2020
Q4 | $284K | Buy |
+1,113
| New | +$284K | ﹤0.01% | 835 |
|
|
2020
Q3 | – | Sell |
-1,222
| Closed | -$424K | – | 1015 |
|
|
2020
Q2 | $424K | Buy |
+1,222
| New | +$424K | 0.01% | 748 |
|
|
2020
Q1 | – | Sell |
-1,277
| Closed | -$413K | – | 740 |
|
|
2019
Q4 | $413K | Sell |
1,277
-418
| -25% | -$135K | 0.01% | 721 |
|
|
2019
Q3 | $463K | Buy |
+1,695
| New | +$463K | 0.01% | 675 |
|